DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the […]
Introducing DrugChatter: Revolutionizing Information Access Read Post »
Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity
The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents Read Post »
Introduction: Navigating the Complex World of Drug Patents Have you ever wondered about the intricate process behind bringing a new
The Intricate Journey of Drug Patents: From Filing to Expiry Read Post »
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area
Uncovering Lucrative Low-Competition Generic Drug Opportunities Read Post »
Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same
Maximizing ROI with Branded Generics: A Comprehensive Guide Read Post »
A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis
A Practical Guide to FtO Analysis for Drug Repurposing Ventures Read Post »
The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice”
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies Read Post »
Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key
Innovative Approaches to Extend the Life of Drug Patents Read Post »
Get fresh news and insights, drug patent expirations & more…
